Skip to main content

Navigation group

Type at least 3 characters
428 articles

Articles

Study Protocol

Published on 24 Aug 2021

A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1

in Autism

  • Mara Parellada
  • Antonia San José Cáceres
  • Melanie Palmer
  • Richard Delorme
  • Emily J. H. Jones
  • Jeremy R. Parr
  • Evdokia Anagnostou
  • Declan G. M. Murphy
  • Eva Loth
  • Paul P. Wang
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.701729
  • 8,566 views
  • 14 citations